(PharmaNewsWire.Com, December 17, 2019 ) Market Overview Heparin is an anticoagulant or blood thinner and is widely used to treat and prevent blood clots in the veins, arteries, or lung.
Heparin is also used before surgeries to reduce the risk of blood clots.
With approximately 500 million doses of heparin being used worldwide every year, the annual market for Heparin was valued at USD 10 billion in 2017.
Market Growth and Trends The market has significant growth opportunities owing to growing potential applications of heparin ranging from anti-inflammatory and anti-tumor applications to prevention of infectious disease and use as nano-carriers for drug delivery.
Also, the rising number of coagulation disorders such as venous thromboembolism (VTE) will also fuel market growth.
However, the wide availability of alternative anticoagulants such as warfarin, coumarins, and oral anticoagulants are expected to hamper heparin sales, thereby negatively impacting market growth.
Market Segmentation The Global Heparin market report segments the market by product type, by source, by formulation, and by region.
Based on product type, the market is categorized into three classes, namely unfractionated heparin, low molecular weight heparin, and ultra-low molecular weight heparin.
Based on the type of formulation, the market is segmented into oral and parenteral. Based on the source, the market is divided into bovine and porcine.
Before the early 1990s, bovine heparin was widely available and used in the US. However, concerns about the use of heparin from bovine sources eventually led to the voluntary withdrawal of all bovine heparin products from the US market.
Geographically, the market is segmented into five major regions, namely North America, South America, Europe, Asia Pacific, and RoW.
North America dominates the market for Heparin, followed closely by Europe.
scope of the Report The report profiles the following companies in Heparin market – Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Fresenius SE & Co. KGaA, Sanofi, Pfizer, Inc., LEO Pharma A/S, Aspen, Baxter International Inc., B. Braun Melsungen AG, and Syntex S.A.
By Product Type Unfractionated Heparin (UFH) Low Molecular Weight Heparin (LMWH) Ultra-low Molecular Weight Heparin (ULMWH)
By Source Type Bovine Porcine
By Formulation Type Oral Parenteral
By Region Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific) Europe (Germany, France, The UK, Italy, Spain, Rest of Europe) North America (The USA, Canada, Mexico) South America (Brazil, Argentina, Rest of South America) Rest of the World
About Us: DataM Intelligence was established on an elemental idea of publishing Advanced Market Research Reports with precise data points & utmost accuracy that will accelerate the decision-making in designing disruptive solutions. We monitor and analyze the market by dissecting various parameters such as market influencers, competitive intensity, innovations, trends, and emerging products.
For more information: Sai Kiran Sales Manager Website: www.datamintelligence.com Email: info@datamintelligence.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
